For the third straight year, Louis P. Kassa III, MPA, chief executive
Menu
The Institute primarily focuses on understanding the pathobiology of hepatitis B virus and related diseases, developing diagnostics for early detection of liver cancer, and discovering therapeutics, antivirals and immune modulators for the cure of chronic HBV and other RNA viruses that cause hepatitis and hemorrhagic fever.
For the treatment of chronic HBV and flavivirus infections such as yellow fever.
The Blumberg Institute Seminar Series, a free and public initiative to promote global scientific exchange, features renowned field leaders such as the 2023 Nobel Prize Laureate Drew Weissman.
The Blumberg Institute Seminar Series, a free and public initiative to promote global scientific exchange, features renowned field leaders such as the 2023 Nobel Prize Laureate Drew Weissman
Our esteemed scientific faculty's expertise spans diverse disciplines, driving innovation and advancing knowledge for a better tomorrow.
The Blumberg Institute is at the forefront of groundbreaking research to understand the hepatitis B virus, develop better treatments, and ultimately find a cure. This life-saving work depends on generous support from donors like you. Your contribution can advance our research and potentially save millions of lives.
The Blumberg Institute, Hepatitis B Foundation and Pennsylvania Biotechnology Center offers transformative education programs for high school students and undergraduate research fellows. Your gift can put lab coats on students, ignite their passion for science, and launch their careers in the life sciences!
For the third straight year, Louis P. Kassa III, MPA, chief executive
Lifesaving research by scientists, doctors and others around our country is being
Four prominent scientists, included one American, Dr. Richard Pestell, have received funding by
The Baruch S. Blumberg Institute, presented the 2024 Lam Excellence in Medicinal
Two scientists with extensive industrial drug discovery and development experience recently joined
Governor Kathy Hochul New York State officials today announced
Dr. Timothy Block will share his thoughts about launching the Foundation, Blumberg
Dr. Fuxuan Wang, a postdoctoral researcher in Dr. Jinhong Chang’s lab at
Joel D. Rosen, Esq, managing partner of High Swartz LLP, has been
Dr. Kunwar Shailubhai Biotech entrepreneur and Blumberg Institute professor Kunwar Shailubhai, PhD,
Support for the research and programs at the Hepatitis B Foundation and Blumberg Institute is being threatened. We need strong action. Every moment we wait puts lives at risk.
Donate now and protect the future of hepatitis B research and treatment.
Stay informed and follow us on social media for updates on how to help us #BeBold.